CIK 0001867096
- Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 871082097
- Phone
- +1 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,678,894
- in 11 filings, $1.7M under 10b5-1 plans
Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Hecht Beth See Remarks | Sale 10b5-1 | −25,000 | $10.23 | $256K | 1,086,130 |
| 2026-10-01 | Hecht Beth See Remarks | Sale 10b5-1 | −16,666 | $9.41 | $157K | 1,111,130 |
| 2026-09-01 | Hecht Beth See Remarks | Sale 10b5-1 | −16,666 | $8.49 | $141K | 1,127,796 |
| 2026-08-03 | Hecht Beth See Remarks | Sale 10b5-1 | −16,666 | $8.01 | $134K | 1,144,462 |
| 2026-07-01 | Hecht Beth See Remarks | Sale 10b5-1 | −16,666 | $8.03 | $134K | 1,161,128 |
| 2026-06-01 | Hecht Beth See Remarks | Sale 10b5-1 | −16,667 | $6.06 | $101K | 1,176,506 |
| 2026-05-01 | Hecht Beth See Remarks | Sale 10b5-1 | −16,667 | $6.23 | $104K | 1,193,173 |
| 2026-04-01 | Hecht Beth See Remarks | Sale 10b5-1 | −16,667 | $5.99 | $100K | 1,209,840 |
| 2026-03-02 | Hecht Beth See Remarks | Sale 10b5-1 | −16,567 | $6.24 | $103K | 1,226,607 |
| 2026-03-02 | Hecht Beth See Remarks | Sale 10b5-1 | −100 | $7.06 | $706 | 1,226,507 |
| 2026-02-02 | Hecht Beth See Remarks | Sale | −16,667 | $7.45 | $124K | 1,243,174 |
| 2026-01-31 | Hecht Beth See Remarks | Shares withheld for taxes | −98,375 | $7.36 | $724K | 1,331,021 |
| 2026-01-31 | Hecht Beth See Remarks | Shares withheld for taxes | −46,914 | $7.36 | $345K | 1,284,107 |
| 2026-01-31 | Hecht Beth See Remarks | Shares withheld for taxes | −24,266 | $7.36 | $179K | 1,259,841 |
| 2026-01-30 | Hecht Beth See Remarks | Grant or award | +121,293 | 1,429,396 | ||
| 2026-01-30 | Hecht Beth See Remarks | Grant or award · Stock Option (Right to Buy) | +162,162 | 162,162 | ||
| 2026-01-02 | Hecht Beth See Remarks | Sale 10b5-1 | −16,667 | $7.43 | $124K | 1,308,103 |
| 2025-12-01 | Hecht Beth See Remarks | Sale 10b5-1 | −16,667 | $7.01 | $117K | 1,320,176 |
| 2025-11-11 | Hecht Beth See Remarks | Sale 10b5-1 | −16,667 | $7.40 | $123K | 1,336,843 |
| 2025-03-20 | Hecht Beth See Remarks | Sale | −40,000 | $5.43 | $217K | 1,353,510 |
Page 1 of 3 · 43 trades